Perception and Prevalence of Fungal Infections in Berlin - Brandenburg (IFI_ICU)
This is a structured web-based survey in selected hospitals with intensive care units in Berlin- Brandenburg that will focus on the analysis of current knowledge in ICUs in the field of invasive mycoses.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Web-based Structured Survey of Retrospective Data of Invasive Mycosis in Intensive Care Patients in Berlin - Brandenburg|
- Perception and prevalence of fungal infections [ Time Frame: 4 months ] [ Designated as safety issue: No ]Perception and prevalence of fungal infections in ICU patients differs from real prevalence and leads to insufficient attribution of importance to this special medical condition.
- Practice - Surrogate markers for diagnosis and therapy of fungal infection and retrospective analysis of cases of invasive mycosis in a peer-review setting. [ Time Frame: 6 months ] [ Designated as safety issue: No ]
Qualitative and quantitative estimation of surrogate markers for diagnosis and treatment of invasive mycosis
Number of bloodcultures per year Rate of bloodcultures positive for fungi ICD-10 diagnosis ICU length of stay for patients with invasive mycosis and/or fungal infection Hospital mortality for patients with invasive mycosis and/or fungal infection Number of patients treated by antimycotics per year Mean duration of antifungal treatment Defined daily doses of antimycotics given by hospital pharmacy
|Study Start Date:||July 2011|
|Study Completion Date:||July 2013|
|Primary Completion Date:||July 2012 (Final data collection date for primary outcome measure)|
Participating hospitals in the INABBRA alliance.
Intensive care patients with invasive mycosis require a special clinical expertise especially in light of a high lethality. Early identification of patients at risk to develop a fungal infection is of utmost importance to start effective antifungal therapy. The implementation of current knowledge into clinical practice to fight fungal infection is not clear.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01393002
|Department of Anesthesiology and Intensive Care Medicine, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitaetsmedizin Berlin|
|Berlin, Germany, 13353|
|Study Director:||Claudia Spies, Prof., MD||Department of Anesthesiology and Intensive Care Medicine, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitaetsmedizin Berlin|